Visual disturbances in advanced cancer patients: Clinical observations

Journal of Pain and Symptom Management

Volumn 17, Issue 3, 1999, Pages 224-226

  Saita, Luigi ^a   Polastri, Daniela ^a   De Conno, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Advanced cancer; Visual disturbances

Indexed keywords

ADVANCED CANCER; ANEMIA; ARTICLE; ASTHENIA; CANCER PATIENT; EYE TUMOR; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PARANEOPLASTIC SYNDROME; VISUAL IMPAIRMENT; VITAMIN DEFICIENCY;

HUMANS; NEOPLASMS; VISION DISORDERS;

EID: 0032975601     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00127-4     Document Type: Article

References (8)

1. Glantz M.J., Biran H., Myers M.E.et al. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer. 73:1994;168-175.
2. Shields J.A., Shields C.L., Kiratli H.et al. Metastatic tumors to the iris in 40 patients. Am J Ophthalm. 119:1995;422-430.
3. Coyle N., Adelhardt J., Foley K.M.et al. Character of terminal illness in the advanced cancer patient. pain and other symptoms during the last 4 weeks of life J Pain Symptom Manage. 5:1990;83-93.
4. Minatel E., Trovò M.G., Forner L.et al. The efficacy of radiotherapy in the treatment of intraocular metastases. Br J Radiol. 66:1993;699-702.
5. Croft PB, Wilkinson M. Carcinomatous neuromyopathy: its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet 1963;i:184-188.
6. Bunn PA Jr, Chester Ridgway E. Paraneoplastic syndromes. In: De Vita VT Jr, Hellman S, Rosenberg SA. Cancer principles and practice of oncology, 4th ed. 1993:2026-2071.
7. Thirkill C.E., FitzGerald P., Sergott R.C.et al. Cancer-associated retinopathy (CAR Syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med. 321:1989;1589-1594.
8. Kornguth S.E., Klein R., Appen R.et al. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 50:1982;1289-1293.